Barrier to Generic Competition Threatens Safe, Low Cost Drug Options

In this PharmExec.com article, "Barrier to Generic Competition Threatens Safe, Low Cost Drug Options," Carlos Angulo and Sasha Miller argue that an increasingly common pharmaceutical brand company tactic is threatening to undermine the entire FDA generic drug approval process.

Related practices
Related people
Media contact

Diana L. Courson
Chief Marketing Officer
Email | 202.778.1871